Abbott Labs (ABT)$87.41
Market Cap: 230.70 BCurrency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Abbott Labs (ABT).
HEALTHCARE
MEDICAL DEVICES
DCF ready
Valuation
31.8x
EV/FCF, 3.1% FCF yield
Quality
10.0%
ROIC, 16.7% FCF margin
Growth
5.1%
5Y sales (revenue) CAGR
Balance sheet
0.2x
Debt/equity, 1.6x current ratio
Superinvestors
6
Top: Jensen Investment Management (3.0%)
Strengths to research
- Free cash flow margin is healthy at 16.7%.
- Debt/equity looks manageable at 0.2x.
- 6 tracked superinvestors report a position.
- 10 annual periods are available for trend analysis.
Watchouts
No major valuation, balance sheet, or growth watchouts were detected by the static screen.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for ABT.
Grade C
64
/ 100
Peer Comparison
Target stock against 5 market-cap comparable peers.
Heat map: red worst to green best
| ABT Target | Abbott Labs | $230.7B | 23.5x | 31.8x | 10.0% | 5.1% | 16.7% | N/A | 0.5x | N/A |
| BSX | Boston Scientific | $154.2B | 29.8x | 41.6x | 11.9% | 15.2% | 18.2% | 69.0% | -0.4x | N/A |
| SYK | Stryker Corp. | $145.6B | 37.7x | 33.0x | 14.5% | 11.8% | 17.1% | 64.0% | -0.6x | N/A |
| MDT | Medtronic plc | $107.0B | 21.8x | 20.2x | 9.7% | 3.0% | 15.5% | N/A | -0.3x | N/A |
| EW | Edwards Lifesciences Corp. | $44.0B | 46.9x | 30.8x | 10.4% | 6.7% | 22.0% | 78.0% | -2.1x | N/A |
| DXCM | DEXCOM, INC. | $31.5B | 34.5x | 28.4x | 30.5% | 19.3% | 23.1% | 60.1% | -0.8x | N/A |
Financial Charts
No financial data available for ABT (annual).
6 superinvestors own ABT
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Lee Ainslie Maverick Capital | 1,758,160 | $181M | 2.10% | 0.0% |
| Jensen Investment Management Jensen Investment Management | 1,486,036 | $153M | 3.01% | 0.0% |
| Mairs & Power Growth Fund Mairs & Power Growth Fund | 721,778 | $74M | 0.76% | 0.0% |
| Dodge & Cox Dodge & Cox | 17,324 | $2M | 0.00% | 0.0% |
| Polen Capital Management Polen Capital Management | 15,081 | $2M | 0.01% | 0.0% |
| Thomas Russo Gardner Russo & Quinn | 11,510 | $1M | 0.01% | 0.0% |